|
Peptides
UBC13 Peptide
Background
UBC13 / Ubiquitin-conjugating enzyme E2N Peptide
Location
15 amino acids near the carboxy terminus of human UBC13.
Application
UBC13 peptide is used for blocking the activity of the Anti-UBC13 antibody (Cat. No. 3373). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 30 min at 37˚C.
Tested Application
Bl
Buffer
PBS containing 0.02% sodium azide
Storage
UBC13 peptide is supplied as 200 μg/ml, 50 μg/vial, in PBS pH7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide. Store at -20˚C, stable for one year.
Species Reactivity
n/a
Species
H
Short Description
UBC13 peptide
This product belongs to the following categories:
Related Products
References- Nakashima T, Sekiguchi T, Kuraoka A, et al. Molecular cloning of a human cDNA encoding a novel protein, DAD1, whose defect causes apoptotic cell death in hamster BHK21 cells. Mol. Cell Biol. 1993; 13:6367-74.
- Stellar H. Mechanisms and genes of cellular suicide. Science 1995; 267:1445-9.
- Gilmore R and Kelleher DJ. DAD1, the defender against apoptotic cell death, is a subunit of the mammalian oligosaccharyltransferase. Proc. Natl. Acad. Sci. USA 1997; 94:4994-9.
- Sanjay A, Fu J, and Kreibich G. DAD1 is required for the function and the structural integrity of the oligosaccharyltransferase complex. J. Biol. Chem. 1998; 273:26094-9.
Datasheet 0801-W
|
|
